Skip to content
  • Home
  • About Us
    • Vision
    • People
      • Team
      • Senior Advisory
      • Medical Advisory
      • Consultants
    • Board
    • Funding
  • Technology
    • Platforms
    • Case Studies
    • Collaborations
    • Publications
    • White Paper
    • Pipeline
  • Media
    • Awards & Recognition
    • Newsroom
    • Blog
    • YouTube
  • Research Oncology Solutions (ROS)
    • Drug Discovery
    • Drug Repurposing
    • Clinical Translations
  • Gallery
  • Contact Us
  • Careers
  • Home
  • About Us
    • Vision
    • People
      • Team
      • Senior Advisory
      • Medical Advisory
      • Consultants
    • Board
    • Funding
      • Investors
      • Grants
  • Technology
    • Platforms
    • Case Studies
    • Collaborations
    • Publications
  • Research Oncology Solutions
    • Drug Discovery/ Drug Repurposing/Clinical Translations
  • Media
    • Awards & Recognitions
    • Newsroom
    • Blog
    • Youtube
  • Gallery
    • People
    • Labs
      • Main Lab
      • Tissue Culture
      • Animal House
      • Incubator
    • Instrumentation
  • Contact Us
  • Careers
  • Home
  • About Us
    • Vision
    • People
      • Team
      • Senior Advisory
      • Medical Advisory
      • Consultants
    • Board
    • Funding
  • Technology
    • Platforms
    • Case Studies
    • Collaborations
    • Publications
    • White Paper
    • Pipeline
  • Media
    • Awards & Recognition
    • Newsroom
    • Blog
    • YouTube
  • Research Oncology Solutions (ROS)
    • Drug Discovery
    • Drug Repurposing
    • Clinical Translations
  • Gallery
  • Contact Us
  • Careers

Mestastop Solutions applies to CDSCO for approval of Ph II clinical trial targeting metastasis

Mestastop Solutions applies to CDSCO for approval of Ph II clinical trial targeting metastasis

Posted on May 16, 2025May 16, 2025 by Mestastop

Recent Posts

  • Mestastop gets a 2.66 Cr grant from BIRAC for extending its proprietary drug discovery models into oral and breast cancer
  • Mestastop Solutions and Ectica Technologies participate in the Swiss Biotech Days 2024
  • Mestastop Solutions and Vipragen Biosciences signs a Memorandum of Understanding.
  • Mestastop Solutions and St Johns Research Institute signed a Research Agreement.
  • Mestastop Solutions and Bangalore BioInnovation Centre collaborates to develop drug discovery models to combat cancer metastasis

Recent Comments

No comments to show.

Archives

  • November 2024
  • April 2024
  • December 2023

Categories

  • Uncategorized
  • Home
  • About Us
  • Technology
  • Research Oncology Solutions
  • Media
  • Gallery
  • Contact Us
  • Careers
  • Privacy Policy
Linkedin Twitter Youtube